Integration of proteomics in the molecular tumor board

Abstract

Cancer remains one of the most complex and challenging diseases in mankind. To address the need for a personalized treatment approach for particularly complex tumor cases, molecular tumor boards (MTBs) have been initiated. MTBs are interdisciplinary teams that perform in‐depth molecular diagnostics to cooperatively and interdisciplinarily advise on the best therapeutic strategy. Current molecular diagnostics are routinely performed on the transcriptomic and genomic levels, aiming to identify tumor‐driving mutations. However, these approaches can only partially capture the actual phenotype and the molecular key players of tumor growth and progression. Thus, direct investigation of the expressed proteins and activated signaling pathways provide valuable complementary information on the tumor‐driving molecular characteristics of the tissue. Technological advancements in mass spectrometry‐based proteomics enable the robust, rapid, and sensitive detection of thousands of proteins in minimal sample amounts, paving the way for clinical proteomics and the probing of oncogenic signaling activity. Therefore, proteomics is currently being integrated into molecular diagnostics within MTBs and holds promising potential in aiding tumor classification and identifying personalized treatment strategies. This review introduces MTBs and describes current clinical proteomics, its potential in precision oncology, and highlights the benefits of multi‐omic data integration.

Proteogenomics in Nephrology: A New Frontier in Nephrological Research

“…These studies have delved into the renal proteome, encompassing the proteomes of specific intrarenal structures such as the glomeruli, tubules, and podocytes. Furthermore, they extend to the analysis of the urinary proteome and the protein profiles in dialysate or ultrafiltrate from renal replacement therapies [1,[3][4][5]. The insights garnered from these proteomic analyses have been instrumental in delineating the pathophysiological landscape of renal diseases, identifying novel biomarkers, and uncovering new therapeutic targets.…”

Nerve Growth Factor and the Role of Inflammation in Tumor Development

“…Inflammatory processes play a multifaceted role in tumor development and progression [1][2][3][4][5][6][7]. While the immune system's inflammatory response is typically a defense mechanism against infections and tissue damage, chronic or persistent inflammation can contribute to the initiation, growth, and spread of certain types of tumors.…”

Editorial: Application of multi-omics technologies to explore novel biological process and molecular function in immunology and oncology

“…Being focused primarily on the quantitative and qualitative assessment of different levels of gene regulation, Multiomics can bring researchers to a next level of integration of functional data including genomic, epigenetic, transcriptomic, proteomic, and metabolomic profiles ( Buzdin et al, 2019 ). This makes it possible to perform high throughput in-depth investigations of molecular mechanisms leading to carcinogenesis in individual cases or to generalize the results on the level of bigger patient cohorts or specific tumor molecular classes ( Bonetti et al, 2023 ; Thiery and Fahrner, 2023 ). One of the most important aspects here deals with the immunity-related mechanisms of tumor growth and cancer therapy ( Wang et al, 2021 ).…”